CLC Number:
- R473.73
| [1] Hashmi1 H, Husnain M, Khan A, et al. CD38-Directed Therapies for Management of Multiple Myeloma[J].ImmunoTargets and Ther,2021,10:201-211.DOI:10.2147/ITT.S259122. [2] Cáceres MC, Guerrero-Martín J, Pérez-Civantos D, et al.The Importance of Early Identification of Infusion-related Reactions to Monoclonal Antibodies[J].Ther Clin Risk Manag, 2019, 15:965-977. DOI:10.2147/TCRM.S204909. [3] 付恩锋,王艳,王洁.70例非小细胞肺癌患者免疫检查点抑制剂不良反应分析及护理对策[J].护理学报,2020, 27(14):68-70. DOI: 10.16460/j.issn1008-9969.2020.14.068. [4] 薛静,张丽燕.消化道肿瘤患者免疫检查点抑制剂治疗所致不良反应的护理[J].护理学报,2019,26(13):63-65.DOI:10.16460/j.issn1008-9969.2019.13.063. [5] 陈仙红,钱颖,阮佳音.达雷木单抗治疗复发难治性多发性骨髓瘤患者的观察和护理[J].天津护理,2021,29(3):323-325. DOI:10.3969/j.issn.1006-9143.2021.03.021. [6] King T, Jagger J, Wood J, et al.Best Practice for the Administration of Daratumumab in Multiple Myeloma[J]. Australian Myeloma Nurse Expert Opinion Asia Pac J Oncol Nurs, 2018,5(3):270-281. DOI:10.4103/apjon.apjon_9_18. [7] Barr H, Dempsey J, Waller A, et al.Ninety-minute Daratumumab Infusion is Safe in Multiple Myeloma[J]. Leukemia,2018,32(11):2495-2518. DOI:10.1038/s41375-018-0120-2. [8] Lokhorst HM, Plesner T, Laubach JP, et al.Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma[J]. N Engl J Med, 2015,373(13):1207-1219.DOI:10.1056/NEJMoa1506348. [9] Moore DC, Arnall JR, Thompson DL, et al.Evaluation of Montelukast for the Prevention of Infusion-related Reactions with Daratumumab[J].Clin Lymphoma Myeloma Leuk, 2020, 20(10):e777-e781. DOI:10.1016/j.clml.2020.05.024. |
| [1] | . [J]. Journal of Nursing, 2022, 29(11): 31-35. |
| [2] | . [J]. Journal of Nursing, 2022, 29(11): 59-64. |
| [3] | LIU He, ZHENG Wei, SU Shan-shan, WANG Dan-dan, LIU Meng-li, QU Xiao-feng. Self-compassion and Its Influence Factors of Patients with Recurrent Gastric Cancer: A 205-case Study [J]. Journal of Nursing, 2022, 29(9): 1-4. |
| [4] | ZOU Zi-yu, TANG Hong-mei, WU Li, CHEN Rong-feng, MEI Hua. Scoping Review of Readability Assessment of Breast Cancer-related Health Education Materials [J]. Journal of Nursing, 2022, 29(9): 42-46. |
| [5] | . [J]. Journal of Nursing, 2022, 29(8): 14-18. |
| [6] | LUO Yu-qin, LI Meng-xuan, CHENG Qiu, WANG Ting, ZHENG Jing-yu, FANG Jin-bo, GONG Yu-ping. Case-control Study on Risk Factors of Perianal Infection in Patients with Hematological Malignancy undergoing Chemotherapy [J]. Journal of Nursing, 2022, 29(7): 7-11. |
| [7] | ZHU Fei, LU Qian, QI Juan, BIAN Ying, PANG Li-sha, LIU Chun-lei. Qualitative Research on Fertility Desire of Breast Cancer Patients in Productive Period [J]. Journal of Nursing, 2022, 29(7): 23-26. |
| [8] | CHEN Ying, HU De-ying, DING Fang. Question, Persuade, and Refer in Training of Inpatient Suicide Prevention for Oncology Nurses [J]. Journal of Nursing, 2022, 29(7): 74-78. |
| [9] | . [J]. Journal of Nursing, 2022, 29(6): 65-70. |
| [10] | LIAO Min, LI Jin-hua, CHEN Jie-jun, CHENG Jing, LI Xing-feng. Effect of Internet-based Rehabilitation Warning Model on Patients with Breast Cancer [J]. Journal of Nursing, 2022, 29(6): 73-78. |
| [11] | SUN Hai-yan, QIN Yang, XU Yi-rong, CHEN Wen-yan. Relationship between Dyadic Coping and Psychological Resilience in Cancer Survivor Couples: An Actor-partner Interdependence Model-based Analysis [J]. Journal of Nursing, 2022, 29(6): 60-64. |
| [12] | CHEN Yong, PENG Si-yi, LIU Xiao-bao, LI Kun-yan, WEI Tao, LI Xu-ying. Construction and Practice of Phase I Clinical Trial Ward in Cancer Hospital [J]. Journal of Nursing, 2022, 29(5): 32-36. |
| [13] | WU Li, CHEN Rong-feng, ZOU Zi-yu, TANG Hong-mei. Clinical Application of Question Prompt List in Breast Cancer Patients: A Systematic Review [J]. Journal of Nursing, 2022, 29(2): 45-50. |
| [14] | . [J]. Journal of Nursing, 2022, 29(1): 25-29. |
| [15] | CUI Han-fei, QIAO Juan, WEI Jing-wen, DONG Feng-qi. Filial Piety Motivation and Experience among Children of Patients with Advanced Cancer: A Qualitative Study [J]. Journal of Nursing, 2021, 28(24): 57-62. |
|